Newsroom

News

Ahead of the “World Antimicrobial Awareness Week” (November 18-24) 20 national and international organizations from academia, healthcare and the pharmaceutical industry appealed today to G7 governments to step up efforts to tackle the problem of growing antibiotic resistance. Their "Joint Statement on Strengthening the Antibiotic R&D Pipeline by Rewarding Innovation" stresses that only an approach involving both the public and private sectors is likely to succeed. The Helmholtz Centre for Infection Research (HZI) is a member of the Helmholtz Association of German Research Centres and the German Center for Infection Research (DZIF), which both signed the statement.

17.11.2021

HZI Campus

News

Researchers from the Helmholtz Centre for Infection Research (HZI) and partners from the University of Bordeaux have established a mechanism that regulates the migration of individual cells. The study was recently published in Nature Cell Biology and discussed in an accompanying article by renowned experts.

16.11.2021

HZI Campus

Illustration von antiviralen Wirkstoffen

News

The Federal Agency for Disruptive Innovation (SPRIND) has announced the participants of the first SPRIND Challenge “A Quantum Leap for New Antiviral Agents”. From 45 applications from Germany and Europe, the jury selected a total of nine teams. Prof Mark Brönstrup from the Helmholtz Centre for Infection Research (HZI) in Braunschweig and Prof Chase Beisel from the Helmholtz Institute for RNA-based Infection Research (HIRI), a joint institution of the HZI with the Julius-Maximilians-Universität Würzburg (JMU), convinced the jury with the projects they led. The HZI scientists Prof Carlos A. Guzmán and Dr Christian Sieben are involved in two other projects as cooperation partners. The teams will each receive up to 700,000 euros in the first year of the three-year competition to develop new drug candidates against viral diseases.

10.11.2021

HZI Campus

HIPS

HIRI

News

The Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung, BMBF) is supporting the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg - an institution of the Helmholtz Centre for Infection Research Braunschweig in cooperation with the Julius-Maximilians-University - with up to 733,000 euros. The grant is awarded to Daphne Collias, a post-doc in Chase Beisel’s lab at HIRI, to take the new and award-winning LEOPARD technology a decisive step further towards commercialization. In the future, LEOPARD may help physicians and patients by providing more comprehensive diagnostic information about a patient’s health. The funding is part of the "GO-Bio initial" program from the BMBF and is granted for a period of 24 months.

03.11.2021

HIRI

Mikroskopieaufnahme einer Infektionsstelle von Leishmania major in der Haut

News

Nitric oxide (NO) occurs naturally in the human body as a messenger substance. It is considered an all-rounder, as it performs numerous important regulatory functions, including immune defense against pathogens. The exact mode of action of this molecule has now been uncovered by immunologist Prof Andreas Müller from the Institute of Molecular and Clinical Immunology at the University Medical Center Magdeburg together with scientists from the Helmholtz Centre for Infection Research (HZI) in Braunschweig. The findings are crucial for the development of new therapeutic approaches for the treatment of infectious diseases, but also of diseases caused by excessive inflammation. The results were published in the renowned journal "Immunity".

25.10.2021

HZI Campus

BRICS

News

The German Center for Infection Research (DZIF) and the Helmholtz Centre for Infection Research (HZI) have developed a concept to form a National Alliance for Pandemic Therapeutics (NA-PATH). They thereby wish to target research and development of widely effective therapeutics in order to be better prepared for future outbreaks due to viral pathogens having pandemic potential. Overcoming the current COVID-19 pandemic will be considerably more difficult due to the deficiency of antiviral active substances.

06.10.2021

HZI Campus

Back to the first page
...
38
39
40
41
...
131

HZI in the media

before and we just didn’t notice?” asks Fabian Leendertz, director of the Helmholtz Institute for One Health. He points out that wildlife

25.06.2025

Resurgence

... Samonellen liegen unter Schwarzlicht im Labor des Helmholtz-Zentrums in Braunschweig. Foto: Peter Steffen/dpa ...

23.06.2025

Kurier

Slevogt from the MHH and the Helmholtz Centre for Infection Research (“Helmholtz-Zentrum für Infektionsforschung“; HZI). An application for

23.06.2025

Trading View

... der Universität des Saarlandes , des Helmholtz-Instituts für Pharmazeutische Forschung Saarland (HIPS) und internationalen Teams ...

19.06.2025

CHIP

Forschende am Helmholtz-Zentrum für Infektionsforschung in Braunschweig (Niedersachsen) arbeiten an einer neuer Impfstoff-Technologie, die

18.06.2025

17:30 SAT.1 REGIONAL

... machen

Die Studie der Wissenschaftler des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig will daher vor ...

18.06.2025

Cityblick 24

including Dr. Max Kellner and Prof.‌ Josef Penninger of the⁢ Helmholtz Center for Infection Research (HZI), explored this ‌resilience.They

17.06.2025

Newsdirectory3

the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Chair of Microbiology of the Julius-Maximilians-Universität Würzburg

17.06.2025

Phys.org

Instituts für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) ...

17.06.2025

DeutschesGesundheitsPortal

Register now for the HZI-Newsletter

and stay up to date!

Email address

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.

Please enter here the word as displayed in the picture. This is to prevent spamming.*

If you can't read the word, click here.